T. Rowe Price Associates’s Claritev Corp CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$476K Buy
+13,929
New +$341K ﹤0.01% 2649
2026
Q1
Sell
-7,746
Closed -$332K 3199
2025
Q4
$332K Sell
7,746
-2,800
-27% -$142K ﹤0.01% 2600
2025
Q3
$560K Buy
10,546
+223
+2% +$12.3K ﹤0.01% 2318
2025
Q2
$466K Buy
+10,323
New +$297K ﹤0.01% 2343
2024
Q4
Sell
-11,049
Closed -$85K 3069
2024
Q3
$85K Buy
11,049
+3,644
+49% +$42.8K ﹤0.01% 2852
2024
Q2
$113K Sell
7,405
-2,773
-27% -$66K ﹤0.01% 2733
2024
Q1
$331K Buy
10,178
+1,655
+19% +$69.7K ﹤0.01% 2393
2023
Q4
$491K Buy
8,523
+230
+3% +$14K ﹤0.01% 2181
2023
Q3
$558K Buy
8,293
+254
+3% +$18.8K ﹤0.01% 2057
2023
Q2
$679K Sell
8,039
-178
-2% -$9.51K ﹤0.01% 1992
2023
Q1
$349K Buy
8,217
+155
+2% +$7K ﹤0.01% 2271
2022
Q4
$371K Sell
8,062
-10,533
-57% -$841K ﹤0.01% 2285
2022
Q3
$2.13M Sell
18,595
-928,943
-98% -$154M ﹤0.01% 1433
2022
Q2
$208M Buy
947,538
+30,494
+3% +$6.03M 0.03% 472
2022
Q1
$172M Sell
917,044
-16,025
-2% -$2.64M 0.02% 573
2021
Q4
$165M Sell
933,069
-410
-0% -$73K 0.01% 607
2021
Q3
$210M Buy
933,479
+50,400
+6% +$13.6M 0.02% 535
2021
Q2
$336M Buy
883,079
+28,284
+3% +$8.76M 0.03% 431
2021
Q1
$190M Buy
854,795
+4,873
+0.6% +$1.4M 0.02% 571
2020
Q4
$272M Buy
849,922
+288,118
+51% +$95.9M 0.03% 445
2020
Q3
$230M Buy
+561,804
New +$247M 0.03% 452

Other funds holding CTEV

T. Rowe Price Associates's CTEV Position: Q2 2026 in Review

T. Rowe Price Associates opened a new position in Claritev Corp (CTEV) in Q2 2026: 13,929 shares worth $476K. The stake represents ﹤0.01% of the portfolio and ranks #2649 among its holdings. This is a return to the name: T. Rowe Price Associates previously reported a position in CTEV as recently as Q4 2025.

T. Rowe Price Associates first reported a position in CTEV in Q3 2020 and has held it in 21 quarters since. The position peaked at $336M in Q2 2021. 102 funds tracked by Wall St. Rank hold CTEV as of Q2 2026.

  • T. Rowe Price Associates held 13,929 shares of Claritev Corp worth $476K as of Q2 2026.
  • Claritev Corp was a new T. Rowe Price Associates position in Q2 2026.
  • Claritev Corp made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2649 holding.
  • T. Rowe Price Associates first reported a position in Claritev Corp in Q3 2020 and has held it in 21 quarters since.
  • T. Rowe Price Associates's Claritev Corp position peaked at $336M in Q2 2021.
  • 102 funds tracked by Wall St. Rank held Claritev Corp as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.